CUSTOMER SERVICE:

OR +1 (800) 643-3426

MENU
My Order 0 0
My Quote My Quote
  • Pooled Human Complement, Neat

Pooled Human Complement, Neat

Human serum collected to preserve complement activity, 0.2 micron filtered, aliquoted, and frozen.
Loading...
Specifications
Pooled
Frozen Liquid
-70°C or below
Assay development & validation, Immunoassays, Non-clinical & preclinical studies, Vaccine development
Learn more

Product Code: Select size

Custom/Bulk request

SEE Bulk Requirements

Bulk Requirements for Human Serum
From
 $12.00
Lead time on this item is currently: 2-4 Weeks

Need help? Ask a Specialist Contact Us OR +1 (800) 643-3426

Product Overview
Product Overview
Application: Assay development & validation, Immunoassays, Non-clinical & preclinical studies, Vaccine development
Storage Conditions: -70°C or below
Shipping Conditions: Dry ice
Species: Human
Application Notes: Suitable as a source of human complement proteins. Complement components are extremely heat-sensitive; for best results, thaw complement on ice or in a cold water bath. Aliquots may be made and frozen at -70°C or below. Avoid multiple freeze-thaw cycles. When a working aliquot is thawed, do not re-freeze remaining complement, but discard it.
Guarantee: Product quality is guaranteed to meet Pel-Freez Biologicals’ specifications for 1 year from the date of receipt by the customer as long as the product is stored in accordance with the indicated storage conditions.
Testing: CH50: >100 Serum tested negative for infectious disease per FDA guidelines.
Packaging: Cryovial, Poly bottle
Product Attributes: Off-the-Clot (OTC)
Donor Sex: Mixed
Donor Type: Pooled
Product Types: Complement
Physical State: Frozen Liquid
Source: OTC Serum (Complement Preserved)
Product Applications
  • Assay development & validation
  • Opsonophagocytic assay
  • Serum bactericidal assay
  • Vaccine development

Product References

Salic acid protects nontypeable Haemophilus influenza from natural IgM and promotes survival in murine respiratory tract.

Jackson, M. D., Wong, S. M. & Akerley, B. J. Sialic acid protects nontypeable haemophilus influenzae from natural igm and promotes survival in murine respiratory tract. Infect. Immun. 89, (2021).
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae

Shaughnessy, J. et al. Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae. Front. Immunol. 11, 2680 (2020).
Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection

Parzych, E. M. et al. Synthetic dna delivery of an optimized and engineered monoclonal antibody provides rapid and prolonged protection against experimental gonococcal infection. MBio 12, 1–13 (2021).
Neisseria meningitidis urethritis outbreak isolates express a novel factor H binding protein variant that is a potential target of group B-directed meningococcal (MenB) …

Tzeng, Y. L. et al. Neisseria meningitidis urethritis outbreak isolates express a novel factor H binding protein variant that is a potential target of group B-Directed meningococcal (menb) vaccines. Infect. Immun. 88, (2020).
Vaccination with Detoxified Leukocidin AB Reduces Bacterial Load in a Staphylococcus aureus Minipig Deep Surgical Wound Infection Model

Fernandez, J. et al. Vaccination with Detoxified Leukocidin AB Reduces Bacterial Load in a Staphylococcus aureus Minipig Deep Surgical Wound Infection Model . J. Infect. Dis. (2021).
Preclinical efficacy of a lipooligosaccharide peptide mimic candidate gonococcal vaccine

Gulati, S. et al. Preclinical efficacy of a lipooligosaccharide peptide mimic candidate Gonococcal vaccine. MBio 10, (2019).
Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae

Gulati, S., Rice, P. A. & Ram, S. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae. in Methods in Molecular Biology vol. 1997 267–280 (Humana Press Inc., 2019).
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria

Shaughnessy, J. et al. Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae. Front. Immunol. 11, (2020).